Drugs / Peripheral blood mononuclear cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01833585 | Apr 2013 → Dec 2017 | atherosclerosis, limb ischemia, ulcer of lower limbs | Mahidol University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peripheral blood mononuclear cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01833585 ↗ |
| Modality | Cell therapy | “G-CSF-mobilized autologous peripheral blood mononuclear cell injection to ischemic limbs” NCT01833585 ↗ |
| Route | Intramuscular | “injected to the gastrocnemius muscle” NCT01833585 ↗ |